摘要
CD6的免疫疗法治疗银屑病和类风湿性关节炎已进入临床试验阶段并取得了明显的进展,单克隆抗体靶向CD6已用于自身免疫和炎症反应的动物模型并且效果良好。然而,CD6单抗治疗的作用方式从未被理解,其充满了不确定性,对CD6的机制和生物功能也充满了争议。CD6最初被发现能刺激受体T淋巴细胞,最近的研究表明,CD6可以调节早期以及后期的T细胞反应。同时,与CD6的粘附性对免疫突触的建立和稳定的贡献相反,实际触发CD6可能诱导T淋巴细胞的抗增殖信号。CD6有一个特别长的胞质尾,其基因将发生特殊的激活依赖剪模式。这一方面可以决定CD6蛋白质是否能结合其配体,另一方面包括或排除传导积极或消极信号的细胞内序列。本文讨论了通过CD6和在能定义T细胞表面分子的双重作用的情况下信号传导性质的多个方面。
关键词: CD6,免疫突触,T淋巴细胞活化,受体抑制剂,选择性剪接,免疫治疗
图形摘要
Current Drug Targets
Title:Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses
Volume: 17 Issue: 6
Author(s): Rita F. Santos, Liliana Oliveira and Alexandre M. Carmo
Affiliation:
关键词: CD6,免疫突触,T淋巴细胞活化,受体抑制剂,选择性剪接,免疫治疗
摘要: CD6 immunotherapy to treat psoriasis and rheumatoid arthritis has reached the clinical trial stage with apparent success, and targeting CD6 with mAbs is being used in several animal models of autoimmunity and neuroinflammation with promising indications. However, the mode of action of the therapeutic CD6 mAbs is far from being understood, reflecting the uncertainties and controversy surrounding the mechanistic and biological functions of CD6. Initially regarded as a co-stimulatory receptor of T lymphocytes, recent studies suggest that CD6 can instead modulate early as well as late T cell responses. Also, opposing the contribution of CD6 adhesiveness in the establishment and stabilization of immunological synapses, the actual triggering of CD6 might induce anti-proliferative signals to the T lymphocyte. CD6 has an unusually long cytoplasmic tail and its gene undergoes peculiar patterns of activation-dependent alternative splicing that can on one hand determine whether or not the CD6 protein binds to its ligand, and on the other include or exclude intracellular sequences that may transduce positive or negative signaling. In this review we discuss the multiple aspects that determine the nature of the signals transmitted via CD6 and the context that may define a dual role for this important T cell surface molecule.
Export Options
About this article
Cite this article as:
Rita F. Santos, Liliana Oliveira and Alexandre M. Carmo , Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses, Current Drug Targets 2016; 17 (6) . https://dx.doi.org/10.2174/1389450116666150531152439
DOI https://dx.doi.org/10.2174/1389450116666150531152439 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells
Current Immunology Reviews (Discontinued) Tissue Transglutaminase Expression During Neural Differentiation of Human Mesenchymal Stem Cells
CNS & Neurological Disorders - Drug Targets Calcineurin Inhibition and Development: Insights from Research Models
Current Enzyme Inhibition The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
Current Pharmaceutical Design T-Cell-Mediated Signalling in Immune, Inflammatory and Angiogenic Processes: The Cascade of Events Leading to Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Royal Jelly Acid, 10-Hydroxy-trans-2-Decenoic Acid, as a Modulator of the Innate Immune Responses
Endocrine, Metabolic & Immune Disorders - Drug Targets Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Current Genomics Chemokines and Chemokine Receptors as Targets in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy Cytokine Polymorphisms in Chronic Inflammatory Diseases with Reference to Occupational Diseases
Current Molecular Medicine New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Antiinflammatory Treatment for Seemingly Non-inflammatory Disorders-Part 2)
Endocrine, Metabolic & Immune Disorders - Drug Targets Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Mechanisms of Herb-Induced Nephrotoxicity
Current Medicinal Chemistry New Therapeutic Targets and Drugs for the Treatment of Asthma
Mini-Reviews in Medicinal Chemistry Clinical Considerations in Developing Dendritic Cell Vaccine Based Immunotherapy Protocols in Cancer
Current Molecular Medicine The Influence of Different Disease States on Rituximab Pharmacokinetics
Current Drug Metabolism Body Mass Index Impact on Disease Activity, Clinical and Sonographic Remission Rates in Patients with Rheumatoid Arthritis
Current Rheumatology Reviews Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy